AU2001242985A1 - New combination of a betablocker and a cholesterol-lowering agent - Google Patents

New combination of a betablocker and a cholesterol-lowering agent

Info

Publication number
AU2001242985A1
AU2001242985A1 AU2001242985A AU2001242985A AU2001242985A1 AU 2001242985 A1 AU2001242985 A1 AU 2001242985A1 AU 2001242985 A AU2001242985 A AU 2001242985A AU 2001242985 A AU2001242985 A AU 2001242985A AU 2001242985 A1 AU2001242985 A1 AU 2001242985A1
Authority
AU
Australia
Prior art keywords
betablocker
cholesterol
lowering agent
new combination
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2001242985A
Other versions
AU2001242985B2 (en
Inventor
Goran Bondjers
Olov Wiklund
John Wikstrand
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0001188A external-priority patent/SE0001188D0/en
Priority claimed from SE0002352A external-priority patent/SE0002352D0/en
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Priority claimed from PCT/SE2001/000663 external-priority patent/WO2001074394A1/en
Publication of AU2001242985A1 publication Critical patent/AU2001242985A1/en
Application granted granted Critical
Publication of AU2001242985B2 publication Critical patent/AU2001242985B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2001242985A 2000-04-03 2001-03-27 New combination of a betablocker and a cholesterol-lowering agent Ceased AU2001242985B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE0001188-2 2000-04-03
SE0001188A SE0001188D0 (en) 2000-04-03 2000-04-03 New combination
SE0002352-3 2000-06-22
SE0002352A SE0002352D0 (en) 2000-06-22 2000-06-22 New combination
PCT/SE2001/000663 WO2001074394A1 (en) 2000-04-03 2001-03-27 New combination of a betablocker and a cholesterol-lowering agent

Publications (2)

Publication Number Publication Date
AU2001242985A1 true AU2001242985A1 (en) 2002-01-03
AU2001242985B2 AU2001242985B2 (en) 2005-02-24

Family

ID=26655059

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001242985A Ceased AU2001242985B2 (en) 2000-04-03 2001-03-27 New combination of a betablocker and a cholesterol-lowering agent
AU4298501A Pending AU4298501A (en) 2000-04-03 2001-03-27 New combination of a betablocker and a cholesterol-lowering agent

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU4298501A Pending AU4298501A (en) 2000-04-03 2001-03-27 New combination of a betablocker and a cholesterol-lowering agent

Country Status (25)

Country Link
US (2) US20030060477A1 (en)
EP (1) EP1272219B1 (en)
JP (1) JP2003528928A (en)
KR (1) KR20020086749A (en)
CN (1) CN1422161A (en)
AR (1) AR030414A1 (en)
AT (1) ATE347909T1 (en)
AU (2) AU2001242985B2 (en)
BR (1) BR0109753A (en)
CA (1) CA2403160A1 (en)
DE (1) DE60125159T2 (en)
EE (1) EE200200570A (en)
ES (1) ES2276774T3 (en)
HK (1) HK1051325A1 (en)
HU (1) HUP0300332A3 (en)
IL (1) IL151589A0 (en)
IS (1) IS6554A (en)
MX (1) MXPA02009705A (en)
MY (1) MY136386A (en)
NO (1) NO20024732L (en)
NZ (1) NZ521351A (en)
PL (1) PL357813A1 (en)
RU (1) RU2002123591A (en)
SK (1) SK14102002A3 (en)
WO (1) WO2001074394A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7790197B2 (en) 2003-06-09 2010-09-07 Warner-Lambert Company Llc Pharmaceutical compositions of atorvastatin
US7314640B2 (en) * 2003-07-11 2008-01-01 Mongkol Sriwongjanya Formulation and process for drug loaded cores
GB0322552D0 (en) 2003-09-26 2003-10-29 Astrazeneca Uk Ltd Therapeutic treatment
ITMI20040145A1 (en) * 2004-01-30 2004-04-30 Acraf L-MOPROLOLO LPIU 'TARTRATO
EP1722758A1 (en) * 2004-02-11 2006-11-22 Athpharma Limited Chronotherapeutic compositions and methods of their use
CN102091068B (en) * 2004-05-03 2012-09-19 詹森药业有限公司 Indole, benzofuran and benzothiophene derivatives as selective androgen receptor modulators (SARMS)
CN101022791B (en) * 2004-06-04 2011-11-16 麦兰实验室公司 Compositions comprising nebivolol
BRPI0621942A2 (en) 2006-08-04 2011-10-18 Aska Pharm Co Ltd a preparation which reduces a concentration of a free fatty acid and / or fibrinogen in the blood, an agent for reducing the amount of a free fatty acid in the blood, an agent for reducing the amount of fibrinogen in the blood, a method for preventing or treating hyperacidemia of free fatty acid, metabolic syndrome, type II diabetes, complications caused by type II diabetes, lipotoxicity, abnormal lipid metabolism, glucose intolerance, impaired insulin secretion, liver fat, hypo-high density lipoproteinemia, or thrombosis, and use of a preparation
GB0624282D0 (en) * 2006-12-05 2007-01-10 Cavalla David Treatment of cachexia
KR20100045344A (en) * 2008-10-23 2010-05-03 한올바이오파마주식회사 Novel controlled release pharmaceutical combination composition comprising the beta adrenoceptor-blockers and the hmg-coa reductase inhibitors
MX344885B (en) * 2008-11-10 2017-01-10 Psicofarma S A De C V Process for obtaining a composition of rosuvastatin calcium and product obtained.
CN102462844A (en) * 2010-11-05 2012-05-23 四川滇虹医药开发有限公司 Tilisolol pharmaceutical composition and its preparation method
WO2013157833A1 (en) * 2012-04-18 2013-10-24 서울대학교산학협력단 Composition including beta-blocker as an active principle for treating or improving obesity, metabolic diseases, and osteopenia
CN103613586B (en) * 2013-11-01 2016-06-08 北京博爱旺康医药科技有限公司 A kind of pure S-of optically-active (-)-arotinolol acid salt and its preparation method and application
CN103626750B (en) * 2013-11-15 2016-02-24 北京博爱旺康医药科技有限公司 A kind of Arotinolol Hydrochlorid and preparation method thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5175187A (en) * 1989-03-06 1992-12-29 Soorianarain Baligadoo Synergistic compositions for the treatment of coronary insufficiency and methods of use thereof
US5455269A (en) * 1989-03-06 1995-10-03 Baligadoo; Soorianarain Synergistic compositions of amiodarone and beta blockers
DE69212646T2 (en) * 1991-03-18 1997-03-13 Sepracor Inc PREPARATION AND PROCESS CONTAINING OPTICALLY PURE S-METOPROLOL
JP2648897B2 (en) * 1991-07-01 1997-09-03 塩野義製薬株式会社 Pyrimidine derivatives
NO177455C (en) * 1993-06-04 1995-09-20 Gerrit Elmenhorst Device for apparatus for making fire-extinguishing foam
CA2251972A1 (en) * 1996-04-17 1997-10-23 Merck & Co., Inc. Combination therapy for reducing the risks associated with cardiovascular disease
SE9602762D0 (en) * 1996-07-12 1996-07-12 Astra Ab Carton and blank for forming the same
US5998458A (en) * 1997-06-25 1999-12-07 University Technology Corporation Method of treating heart failure
GT199800126A (en) * 1997-08-29 2000-01-29 COMBINATION THERAPY.
EP1354604A1 (en) * 1998-12-23 2003-10-22 G.D. Searle LLC. Combinations for cardiovascular indications

Similar Documents

Publication Publication Date Title
AU2001285020A1 (en) P97-active agent conjugates and their methods of use
AU2002235128A1 (en) Expression miniarrays and uses thereof
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2002223275A1 (en) A method of expression and agents identified thereby
AU2001242985A1 (en) New combination of a betablocker and a cholesterol-lowering agent
AU2001281006A1 (en) Combination of huperzine and nicotinic compounds as a neuroprotective agent
AU4298501A (en) New combination of a betablocker and a cholesterol-lowering agent
AU3622600A (en) Metalloproteinases and methods of use therefor
AU2001235506A1 (en) Dermatological use and a dermatological preparation
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
IL144662A0 (en) Use of cholesterol-lowering agent
AU1053501A (en) Polyazanaphthalene compound and medicinal use thereof
AU4432001A (en) Trityl-type compounds and their use
IL153245A0 (en) New formulation comprising a betablocker and optionally a cholesterol-lowering agent
AU2001234180A1 (en) Benzamide derivative and use thereof
AU2001239631A1 (en) A new oligomer compound and a use thereof
ZA200207107B (en) New combination of a betablocker and a cholesterol-lowering agent.
AU2001288196A1 (en) Tracheostomy tube and use of a coniostomy tube as a tracheostomy tube
AU2001252710A1 (en) Chemically amplified resist and a resist composition
AU2000274552A1 (en) An open construction of a can
AU2001258330A1 (en) New uses of imidazolylmethyl-pyridines
AU2002215923A1 (en) Use of medicaments
AU2001255708A1 (en) Synthesis and use of thienotriazolodiazepines
AU2002223707A1 (en) A new use of a pyridazinone derivative